banner
SGLT inhibitor Tofogliflozin hydrate, Purity ≥98%
Inquiry

Cat. No.: X24-07-ZQ531

SGLT inhibitor Tofogliflozin hydrate, Purity ≥98%

Synonym: 1201913-82-7; SGLT inhibitor; CSG-452 hydrate; CSG452; CSG 452

  • CAS Number: 1201913-82-7
  • Compound CID: 46908928
img
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Tofogliflozin hydrate, soluble in DMSO, water and ethanol, is a sodium-glucose cotransporter inhibitor, preventing the kidneys from reabsorbing glucose.
Molecular Weight
404.45
Molecular Formula
C22H28O7
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 82 mg/mL (202.74 mM); Water: 4 mg/mL (9.88 mM); Ethanol: 82 mg/mL (202.74 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
Tofogliflozin hydrate is an SGLT inhibitor used to assess its efficacy in lowering blood glucose levels for diabetes research.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0